Tandem Diabetes Care, Inc.

51
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US8753722037
USD
20.71
1.09 (5.56%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Tandem Diabetes Care, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-91.00
-220.00
-92.00
15.00
-36.00
-24.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-11.00
-17.00
-4.00
14.00
-36.00
-12.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
24.00
-31.00
50.00
111.00
24.00
41.00
Cash Flow from Investing Activities
-23.00
-85.00
33.00
-186.00
-296.00
-56.00
Cash Flow from Financing Activities
8.00
4.00
16.00
51.00
314.00
24.00
Net Cash Inflow / Outflow
10.00
-113.00
101.00
-23.00
43.00
9.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
1.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Tandem Diabetes Care, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
-91.87
-162.073
71.00
43.32%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-11.781
-67.274
56.00
82.49%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
24.225
-44.651
68.00
154.25%
Cash Flow from Investing Activities
-23.482
-93.136
70.00
74.79%
Cash Flow from Financing Activities
8.367
56.208
-48.00
-85.11%
Net Cash Inflow / Outflow
10.366
-82.13
92.00
112.62%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
1.256
-0.551
1.00
327.95%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 176.16% vs -163.04% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
24.23
-31.81
176.16%